Testing for BRCA mutations linked to breast and ovarian cancers could become easier and more accessible with the help of artificial intelligence, potentially allowing earlier treatment. A partnership ...
For over a decade, Ruth has written for multiple outlets providing patient education, including Health. She has written for health student education companies, collaborating on an anatomy textbook ...
Rucaparib received FDA approval for BRCA-mutated mCRPC after prior androgen receptor–directed therapy, based on the TRITON3 trial results. The trial demonstrated significant improvement in ...
New research indicates that a long-maligned menopausal treatment is safer than previously thought, showing that it doesn’t increase breast cancer risk in women with inherited mutations in the BRCA1 or ...
Although cancer is not usually inherited, certain types, including breast and ovarian, can be triggered by inherited gene faults, meaning they can run in families. Now that we can test for these ...
A Long Island nurse is sharing a message of action in the face of a frightening genetic finding. She learned she was positive for the BRCA mutation, which increases the risk of cancers, but she took ...
After having a preventative double mastectomy, Devin Sidell wanted to make a movie about her experience Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in Billboard ...
Time is running out for people with Jewish ancestry to get the BRCA test from the NHS – crucial for discovering a heightened risk of a range of cancers. We spoke to three women about their BRCA ...
The Republic First Bank situation is once again simmering. Just before Labor Day weekend, the Norcross-Braca Group – comprising George Norcross III, Gregory Braca and Philip Norcross – filed an ...
Two decades ago, a pivotal exchange between two scientists sparked a scientific and medical revolution. Professor Alan Ashworth, then Director of the Breast Cancer Now Toby Robins Research Centre at ...
Patients with BRCA-mutant breast cancer had a significantly higher risk of breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL), a large cohort study showed. BRCA1/2 mutations conferred ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results